Published in Medical Letter on the CDC and FDA, May 13th, 1996
Analysis of all known strains of the virus show that while its four main subgroups differ dramatically, there is astonishing genetic stability within each subgroup.
"The apparent stability of each subtype bodes well for the development of effective immune or antiviral therapy or vaccination strategies," wrote researchers Anthony Sanchez and colleagues of the Special Pathogens Branch of the National Center for Infectious Diseases at the U.S. Centers for Disease Control and Prevention (CDC).
Sanchez et al. reported their findings in the Proceedings of the National Academy of Sciences...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA